Park Avenue Securities LLC Castle Biosciences Inc Transaction History

Park Avenue Securities LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 27, 2022	SELL	$16.0 - $45.99 $103,648 - $297,923	-6,478 Closed	0 $0
Q1 2022 Apr 29, 2022	BUY	$33.17 - $46.98 $214,875 - $304,336	6,478 New	6,478 $291,000
Q4 2021 Apr 08, 2022	SELL	$39.06 - $67.58 $143,350 - $248,018	-3,670 Closed	0 $0
Q3 2021 Oct 21, 2021	BUY	$60.13 - $77.6 $38,002 - $49,043	632 Added 20.8%	3,670 $244,000
Q2 2021 Aug 05, 2021	BUY	$50.07 - $76.78 $152,112 - $233,257	3,038 New	3,038 $223,000

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Park Avenue Securities LLC, based on Form 13F filings with the SEC.

Stay updated on Park Avenue Securities LLC with notifications on news.